Status:
RECRUITING
Efficacy and Safety Between Different Dilution of Insulin
Lead Sponsor:
Universiti Sains Malaysia
Conditions:
Hyperglycemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hyperglycemia associated with insulin resistance is common in critically ill patients, even in those nondiabetic patients. Hyperglycaemia or relative insulin deficiency (or both) during critical illne...
Eligibility Criteria
Inclusion
- Patient admitted to ICU Hospital USM regardless of whether patient intubated or not.
- Adult patient 18 years old and above.
- 2 consecutive blood sugar more than 10 mmol/L including patient with diabetic ketoacidosis and hyperosmolar hyperglycaemic state.
- Within 12 hours from admission.
- Patient not in high inotropic support and with APACHE II score less than 17.
Exclusion
- Pregnancy.
- History of any allergic from previous gelafundin infusion or known patient to have allergic towards gelafundin (allergic card, or information from relatives)
- Post cardiac arrest or prolonged resuscitation.
- Patient with cardiogenic shock.
Key Trial Info
Start Date :
January 9 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT06180824
Start Date
January 9 2024
End Date
December 31 2024
Last Update
May 1 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohd Zulfakar Mazlan
Kota Bharu, Kelantan, Malaysia, 16150